BioSig Technologies, Inc. (BSGM) Financial Statements
Industry: Security & Commodity Brokers, Dealers, Exchanges & Services
Net income was -$462.8M, or -$9.65 per diluted share. Operating activities generated -$10.4M of cash, leaving -$10.4M of free cash flow. At fiscal year end, BioSig Technologies held $187.5M in total assets against $54.2M in total liabilities, including $20.3M of cash and equivalents.
Open the full interactive BioSig Technologies financials → Quarterly statements, key ratios, valuation history and price charts.
BioSig Technologies Key Stats
| Share Price | $0.46 |
|---|---|
| Market Cap | $83.4M |
| 52-Week Range | $0.46 – $6.21 |
| Shares Outstanding | 182.0 million (basic, 2026 Q2) |
BioSig Technologies Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $441,000 | $286,000 | $18,000 | $40,000 | — |
| Cost of Goods Sold | — | $199,000 | $57,000 | — | — | — |
| Gross Profit | — | $242,000 | $229,000 | $18,000 | — | — |
| Operating Income | -$59.2M | -$33.4M | -$27.3M | -$28.5M | -$12.9M | -$71.1M |
| Pre-Tax Income | -$59.1M | -$32.9M | -$27.3M | -$28.7M | -$10.3M | -$464.0M |
| Income Tax | $0 | $0 | $0 | $351,000 | -$9,000 | -$1.3M |
| Net Income | -$52.2M | -$31.9M | -$27.1M | -$29.0M | -$10.3M | -$462.8M |
| Diluted EPS | -$18.70 | — | — | -$3.95 | -$0.75 | -$9.65 |
BioSig Technologies Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | — | — | — | $146,000 |
| Net Income | -$15.6M | -$424.0M | -$46.7M | -$14.6M |
| Diluted EPS | -$0.47 | -$8.84 | -$0.27 | -$0.08 |
BioSig Technologies Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.3M | $11.7M | $400,000 | $200,000 | — | $20.3M |
| Current Assets | $29.3M | $13.9M | $1.1M | $528,000 | $344,000 | $71.9M |
| Total Assets | $30.4M | $15.5M | $4.1M | $1.8M | $842,000 | $187.5M |
| Current Liabilities | $5.1M | $2.6M | $3.3M | $4.6M | $2.3M | $42.8M |
| Total Long-Term Debt | — | — | — | — | — | $50.9M |
| Total Liabilities | $6.0M | $3.0M | $3.7M | $4.7M | $2.3M | $54.2M |
| Shareholders' Equity | $24.4M | $12.2M | $313,000 | -$3.0M | -$1.5M | $133.2M |
BioSig Technologies Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$26.6M | -$26.4M | -$21.7M | -$17.3M | -$4.8M | -$10.4M |
| Cash From Investing | -$87,000 | -$542,000 | -$168,000 | -$186,000 | — | -$24.2M |
| Cash From Financing | $42.8M | $10.3M | $10.6M | $17.3M | $4.7M | $54.9M |
| Free Cash Flow | -$26.7M | -$26.9M | -$21.9M | -$17.5M | -$4.8M | -$10.4M |
Figures from BioSig Technologies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full BioSig Technologies financials page for every line item.
BioSig Technologies Company Profile
| Ticker | BSGM |
|---|---|
| Exchange | Nasdaq |
| Industry | Security & Commodity Brokers, Dealers, Exchanges & Services |
| Headquarters | Winter Park, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001530766 |
Frequently Asked Questions
What is BioSig Technologies' annual revenue history?
BioSig Technologies' annual revenue by fiscal year: 2020: $0; 2021: $441,000; 2022: $286,000; 2023: $18,000; 2024: $40,000.
What was BioSig Technologies' net income in fiscal 2025?
BioSig Technologies reported net income of -$462.8M for fiscal 2025.
What was BioSig Technologies' earnings per share (EPS) in fiscal 2025?
BioSig Technologies' diluted EPS was -$9.65 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did BioSig Technologies generate in fiscal 2025?
BioSig Technologies generated -$10.4M of free cash flow in fiscal 2025.
What was BioSig Technologies' revenue last quarter?
In its most recent reported quarter (2026 Q2), BioSig Technologies reported revenue of $146,000.
How much debt does BioSig Technologies have?
BioSig Technologies reported $50.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of BioSig Technologies are outstanding?
BioSig Technologies reported a weighted average of 182.0 million basic shares outstanding in 2026 Q2.
What is BioSig Technologies' market cap?
Based on its latest closing price, BioSig Technologies (BSGM) has a market capitalization of about $83.4M.
When does BioSig Technologies' fiscal year end?
BioSig Technologies' fiscal year end, as registered with the SEC, is December 31.
Where is BioSig Technologies headquartered?
BioSig Technologies lists its business address in Winter Park, Florida in its SEC filings.
BioSig Technologies Competitors & Similar Companies
See all 10 Security & Commodity Brokers, Dealers, Exchanges & Services companies →